After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...

Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

The software can determine the extent and severity of coronary plaque build-up implicated in coronary artery disease.

The study found that having aCAC score was valuable. First, it provided extra information about risk – for half of these ...

Humanitarianism is about building the kind of world we want to live in. Change isn’t optional but a responsibility. So…let’s act with urgency, compassion and purpose. The heart of the movement is ...

If you've lost a family member prematurely to heart disease, greater reassurance about your risk of suffering the same fate ...

Improving Global Outcomes organization's updates to its 2024 guidelines expand SGLT2 inhibitor use and refine chronic kidney ...

Traditionally, high cholesterol was considered the primary risk factor for CVD. However, research now highlights the central ...

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

What Lies Ahead for Praluent? Projections indicate that the Praluent market will continue its upward trajectory in the coming years: .Market Value Forecast: Expected to reach $XX million by 2029.

Blood pressure trajectories were differently associated with cardiovascular disease risk among men and women with type 1 diabetes.

Coronary artery disease, CAD, is a condition where the arteries that supply blood to the heart muscle become clogged and narrow, making it difficult for blood and oxygen to reach the muscles of ...